Dr. Stolovitzky offers a non-surgical procedure for patients who suffer from repeat nasal polyps with SINUVA™ (mometasone furoate) Sinus Implant. SINUVA is proven to reduce polyps and nasal congestion and obstruction.
What Is SINUVA
SINUVA is a sinus implant that treats nasal polyps without surgery. During a routine office visit, a physician will use topical and/or local anesthesia to numb your nose and sinuses. SINUVA is then placed in the sinus cavity through the nasal opening.
How SINUVA Works
Its innovative design provides a 2-in-1 approach: it is designed to open in the sinus cavity and release anti-inflammatory medicine to treat nasal polyps for up to 90 days.
After 90 days, patients reported:
- Significantly reduces nasal obstruction and congestion
- Significantly improves impaired sense of smell
The most common adverse reactions observed in a clinical trial were bronchitis, upper respiratory or middle ear infection, headache, light-headedness, asthma and nosebleed.
SINUVA is indicated for adults with nasal polyps who have had ethmoid sinus surgery.
The Sinuva implant is designed for the in-office treatment of chronic sinusitis with polyps in patients who have had previous sinus surgery. Clinical research proved that the Sinuva implant is a safe and effective treatment for recurrent polyps.1Dr. Pablo Stolovitzky was one of the National Principal Investigators in charge of Sinuva clinical trials.
Call Dr. Stolovitzky at (404) 921-5474 for more information or to schedule an appointment.
 In-office Placement of Mometasone Furoate Sinus Implants for Recurrent Nasal Polyps: A Pooled Analysis. Stolovitzky JP, Kern RC, Han JK, et.al. Am J Rhinol Allergy. 2019 Sep;33(5):545-558.